Blood Test May Detect Stroke Type Before Hospital Arrival
A blood test measuring GFAP levels may help emergency responders differentiate between hemorrhagic and ischemic strokes.
A blood test measuring GFAP levels may help emergency responders differentiate between hemorrhagic and ischemic strokes.
A screening test for strokes in children with sickle cell disease has existed for decades, yet many patients have never been told of it, an example of racial inequity in the healthcare system, reports the New York Times.
New coalition members commit to improving diagnostic quality, joining 45 prominent organizations in healthcare and patient advocacy.
Quest Diagnostics has approved a definitive agreement to acquire Cleveland HeartLab, with the intent of establishing a national center of excellence in heart disease diagnostic information services.
Read MoreA scientific statement from the American Heart Association determines that the Corus CAD blood test is useful in diagnosing suspected coronary artery disease.
Read MoreQuest Diagnostics will begin providing nonfasting cholesterol tests designed to improve the assessment of heart disease risk.
Read MoreThis month’s issue features a molecular diagnostics system from XimedicaDx, a clinical chemistry analyzer from Randox Laboratories, and a sorting instrument from Yaskawa Motoman.
Read MoreThe device blends enhanced slow-flow rates with precision dispensing for increased application flexibility across a wide volume range.
Read MoreClinicians are using pharmacogenomic testing to identify gene-drug interactions to guide precise patient therapies.
Read MoreDavid A. Ahlquist, MD, coinventor of the Cologuard stool-based DNA screening test for colorectal cancer, discusses updated USPSTF guidelines that seek to increase screening rates.
Read MoreThe number of people living with diabetes and its prevalence are growing in all regions of the world.
Read MoreCandidates have demonstrated comparable preclinical efficacy to existing anticoagulants but with substantially lower bleeding liability.
Read MoreCurrent and emerging cardiac markers are signaling improved testing for better patient outcomes.
Read MoreThe conclusion to our three-part series exploring the value of diagnostics.
Read MoreThe DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.
Read MoreLab professionals can expect that flow cytometry will continue to evolve in new directions with even greater utility for clinical testing.
Read MoreThe biennial ASCP vacancy survey has captured a profession in transition.
Read MoreOver the past decade, the number of hospital admissions for sepsis following healthcare-associated infections and community-acquired infections has increased up to three-fold.
Read More